[1]
Dr. Harkiratjit Singh Bhulla, Dr. Kamalpreet Kaur, and Dr. Pardeep Garg, “LOW-DOSE NIVOLUMAB IN ADVANCED SOLID TUMOURS: ACTIVITY, TOXICITY AND THE MISSING COMPARISON WITH STANDARD DOSE”, J Popl Ther Clin Pharmacol, vol. 32, no. 11, pp. 2230–2247, Dec. 2025, doi: 10.67145/fchabf12.